compound semaglutide ban update Fifth Circuit probes FDA on compounded GLP-1s FDA moves to remove GLP-1

Taken together, supplementation emerges as a potential therapeutic strategy for post-acute sequelae [76] NCT06992414)

The company references weight-loss outcomes associated with semaglutide, including a figure of "15-20% average body weight loss." Those figures are tied to broader clinical literature about FDA-approved branded semaglutide products studied in formal clinical trials and should not be interpreted as established outcomes for the compounded formulations dispensed through this telehealth platform

Use these under medical advice, especially since overuse could swing you toward diarrhoea - its a delicate balance

Immune Compromise: If you have a severely weakened immune system, consult your doctor before taking live bacteria